ETHOS II (@ETHOSII) header
ETHOS II (@ETHOSII) profile picture

Ongoing @KirbyInstitute research aiming to enhance HCV diagnosis and treatment for people who inject drugs. Passionate about eliminating HCV and #HealthForAll.

Australia
Joined May 2019
Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)Photo by ETHOS II (@ETHOSII)
For more information on the issue of equitable #HCV care for women and people who use drugs, read the full study published by @ijdrugpolicy here: 📕doi.org/10.1016/j.drugpo.202… 📕
3
3
241
ETHOS II retweeted
As the world celebrated International Women’s Day, a new briefing document with @Hep_Alliance was released to shed light on the unique challenges faced by women living with viral hepatitis: Read it here➡️ worldhepatitisalliance.org/w… #Hepatitis #WomensHealth #NoHep
3
8
291
In recognition of #InternationalWomensDay2024, NDARC invites you to join us for a discussion on the #gender-specific obstacles that women who inject drugs encounter when seeking #hepatitis C treatment and care. 🗓️ Thursday, 7 March ⏰ 3 pm 🔗us06web.zoom.us/webinar/regi…
3
6
459
🌈 From all of us at the Kirby Institute, we wish our LGBTQIA+ family a Happy Mardi Gras! We’re proud to work in partnership with many individuals and organisations, who help us in our mission to find effective, community-centred health solutions for infectious diseases. ‍🏳️‍🌈🏳️‍⚧️
1
5
1
25
1,498
Next Tuesday at our Seminar Series, Kirby’s @banAnnaConway will present her research on changes to the availability of naloxone & opioid agonist treatment & the effects of the COVID-19 pandemic 📅 1pm AEDT, Tue 13 Feb 💻 Online & in-person event | Free 🗣 kirby.unsw.edu.au/events/dev…
3
3
647
ETHOS II retweeted
✊🏽🚌🩸💉Peers On Wheels (POW) is so much more than just a van! 🥳 POW is a new pilot project NUAA has launched to deliver mobile peer-led testing and treatment services for hepatitis C (hep C).🩸👈 — It's the first of its kind in NSW! 👀 Read here: usersnews.com.au/home/peers-…
3
6
1
23
Join us Nov 25, 1pm Sydney time for a focus on living experience in Spotlight on Stigma series. Facilitated by @Annie_Madden_ with a dazzling range of speakers: Michelle Tobin, Tony McNaughton, Nafisa Yussf. eventbrite.com.au/e/living-e…
9
1
20
New study from @ETHOSII ➡️ only a third of people who reported overdose in last year had ever accessed take home naloxone #InternationalOverdoseAwarenessDay Article free here: https://teapawt.org/t.co/ydzTKWmLHn @jasongrebely @INHepSU
1
14
22
‘Connecting with Care’ by Conor Emotional video from Iran ENHANCE study. We must always remember that their are REAL people behind the #HepC diagnosis. So powerful when we see people’s journey & best part of our project. Favourite session of #INHSU19 @Alavi_Mrym @KirbyInstitute
1
4
14
Highlighting key barriers and facilitators to engaging in #HCV management among GPs and drug treatment specialists at #INHSU19 - @ETHOSII Great presentation from Alison Marshall @KirbyInstitute @CSRH_UNSW @carlatreloar @GregDore2
8
23
#HCV treatment uptake of 65% among PWID in Australia in data presented from the ETHOS Engage study @ETHOSII. Current #HCV infection reduced to 24%. Great work @valerio_heather! @KirbyInstitute #INHSU19 @INHepSU
10
28
ETHOS Engage Study: Uptake of #HCV testing & treatment among people who inject drugs in #Australia 🇦🇺: https://teapawt.org/t.co/rl5e6b7n2C #ILC2019 #HepC #PWID @EASLedu
5
10
Proud to see my PhD student @valerio_heather @KirbyInstitute co-supervised with @GregDore2 present data from the ETHOS ENGAGE study @ #ILC2019 demonstrating #HCV treatment uptake of 59%. HCV prevalence was 27%, demonstrating progress towards elimination among PWID in Australia.
6
36